| Catalog Number | orb61015 |
|---|---|
| CAS Number | 302962-49-8 |
| Application notes | BDS |
| Note | For research use only. |
| Expiration Date | 12 months from date of receipt. |
| Description | Dasatinib (BMS-354825, Sprycel) is a novel, potent and multi-targeted inhibitor that targets Abl, Src and c-Kit, with IC50 of ＜1 nM, 0.5 nM and 79 nM, respectively. Dasatinib has entered in a phase II clinical trial in the treatment of hemangiopericytoma and gastrointestinal stromal tumor. |
Dasatinib (BMS-354825) Chemical Structure
